Asset Publisher

EGEA

Duration
2003-
Coordinator
Francine Kauffmann (INSERM)
The Epidemiological Study of the Genetics and Environment of Asthma (EGEA)

combined a case-control study and a family study. The total sample of 1,854

consisted of 348 patients with asthma selected through chest clinics and 416

control subjects and nuclear families ascertained through the cases. The protocol

included standardized questionnaires, bronchial responsiveness, allergen

skin-prick tests according to international protocols, total serum immunoglobulin

E (IgE) level measurements, and blood eosinophilia.

Criteria used to select subjects with asthma and determine asthma status of relatives for affected sibling pair linkage analysis are described. Based on figures from the 348 asthma cases of the EGEA study, issues relative to the definition of severe asthma and intermediate phenotypes such as bronchial responsiveness and allergic markers are discussed. Given the phenotypic heterogeneity involved, relevant phenotypes that  may lead to the detection of genetic factors will depend on the hypothesis tested. Standardization of primary data and subphenotypes is a prerequisite for pooling data, which will be needed in the future to better understand the genetics and environmental factors of asthma.

 

Website

Our Team

Principal Investigator (PI)

  • Josep M. Antó Boqué
    Josep M. Antó Boqué

Our Team

Other projects

AM-MENTAL

What happens with your mental health when your supervisor is an algorithm?

e-QuoL

e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families

B-Triage

Una prueba en el punto de atención para la estratificación del riesgo de los pacientes febriles basada en los niveles de sTREM-1

IHEN

International Human Exposome Network

EXPONIT

Analysing and studying how night shift work affects workers' circadian rhythms and health

FINDOOR

FTIR spectroscopy for real-time detection of bacterial outbreaks and the rapid identification of pathogenic serotypes, relapsing infections and antibiotic resistance

intoDBP

Innovative Tools to Control Organic Matter and Disinfection Byproducts in Drinking Water

null